scholarly journals Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy

2011 ◽  
Vol 11 (1) ◽  
Author(s):  
Lars Knudsen ◽  
Alexander Schurawlew ◽  
Nils Nickel ◽  
Henning Tiede ◽  
Hossein A Ghofrani ◽  
...  
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Idiopathic Pulmonary Arterial Hypertension ◽  
Parenteral Therapy ◽  
Long Term Effects ◽  
Pulmonary Arterial

scholarly journals Long-term Effects of Epoprostenol on the Pulmonary Vasculature in Idiopathic Pulmonary Arterial Hypertension

CHEST Journal ◽  
2010 ◽  
Vol 138 (5) ◽  
pp. 1234-1239 ◽  
Author(s):  
Stuart Rich ◽  
Jennifer Pogoriler ◽  
Aliya N. Husain ◽  
Peter T. Toth ◽  
Mardi Gomberg-Maitland ◽  
...  
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Idiopathic Pulmonary Arterial Hypertension ◽  
Pulmonary Vasculature ◽  
Long Term Effects ◽  
Pulmonary Arterial

scholarly journals Long-Term Survival in Idiopathic Pulmonary Arterial Hypertension Associated with Massive Pulmonary Artery Dilation

2011 ◽  
Vol 18 (3) ◽  
pp. e50-e51 ◽  
Author(s):  
Vanja Petrovic ◽  
Christopher J Ryerson ◽  
Robert D Levy
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Present Report ◽  
Pulmonary Arteries ◽  
Idiopathic Pulmonary Arterial Hypertension ◽  
Channel Blockers ◽  
Term Survival ◽  
Long Term Survival ◽  
Pulmonary Arterial

The present report describes two patients with long-term survival after being diagnosed with idiopathic pulmonary arterial hypertension more than 20 years earlier. Both patients were treated with calcium channel blockers for several years and are currently maintained on bosentan, an oral endothelin receptor antagonist. Severe dilation of the main pulmonary arteries is present in both patients and may be related to long-term survival with idiopathic pulmonary arterial hypertension.

Sign in / Sign up

Export Citation Format

Share Document